Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD
Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also...
Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also...
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease...
ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor currently under development in moderate-to-severe plaque psoriasis and...
A Former Health System CEO, Mr. Statuto Has Over 30 Years of Leadership Experience CHARLES TOWN, W.V., March 7, 2025...
PORTLAND, Maine, March 6, 2025 /PRNewswire/ -- MedRhythms today announced that MR-005, the company's neurorehabilitation system to support gait rehabilitation...
COLUMBUS, Ohio, March 6, 2025 /PRNewswire/ -- Today, clinical trials dramatically underrepresent patients who live in rural areas of the...
FAIRFAX, Va., March 4, 2025 /PRNewswire/ -- Team Goldbelt, comprised of Goldbelt Apex, LLC, Knowesis, Inc., and zCore Business Solutions...
DELRAY BEACH, Fla., March 4, 2025 /PRNewswire/ -- The global AI in Remote Patient Monitoring Market, valued at US$1551.8 million...
DALLAS, March 4, 2025 /PRNewswire/ -- Homecare HomebaseSM (HCHB), the leading software provider for home-based care, has named Janie "Heather"...
Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheetSOUTH SAN FRANCISCO, Calif. and LOS ANGELES,...
Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheet LOS ANGELES and SOUTH SAN FRANCISCO,...
RALEIGH, N.C., March 03, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, is pleased to announce that the U.S. Food and Drug...
LSPedia's OneScan Suite Transforms Healthcare Operations with Seamless FDA DSCSA Compliance, Integration, and Unmatched Supply Chain Insights. FARMINGTON HILLS, Mich.,...
SEAL Future Foundation joins forces to expand safe access to psychedelic-assisted therapies “Guidance Integration Platform” to provide integration resources for...
HOUSTON, TX, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader...
On track to announce the primary endpoint result from the atacicept pivotal Phase 3 ORIGIN trial in IgA Nephropathy (IgAN)...
CHICAGO, Feb. 25, 2025 /PRNewswire/ -- RedMane Technology today released a white paper focusing on the crucial role AI can...
BELFAST, Northern Ireland, Feb. 24, 2025 /PRNewswire/ -- Neurovalens, a global leader in noninvasive neurostimulation technology, is making significant strides...
SCOTTSDALE, Ariz., Feb. 20, 2025 /PRNewswire/ -- GlobalMed, a global leader in digital health solutions, is proud to announce a...
SCOTTSDALE, Ariz., Feb. 20, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) a national operator, manager, and franchisor of chiropractic...